Axtamova M. N. (1)
This review summarizes recent advances (2020-2025) in the epidemiology, diagnosis, management, and outcomes of liver diseases during pregnancy. Both gestation-specific hepatic disorders (such as intrahepatic cholestasis of pregnancy, HELLP syndrome, acute fatty liver of pregnancy) and preexisting or comorbid chronic liver diseases (autoimmune hepatitis, viral hepatitis, metabolic steatosis, cirrhosis, Wilson’s disease) are discussed. Emphasis is placed on recent guidelines (FIGO, AGA, EASL), risk stratification, diagnostic tools, safety of therapies, maternal and fetal outcomes, and areas for future research.
1. FIGO Guideline on Liver Disease and Pregnancy. International Federation of Gynecology & Obstetrics, 2025; 170(1):28–48. doi:10.1002/ijgo.70161.
2. Pregnancy in Chronic Liver Disease: Before and After Transplantation. Liver International, 2021.
3. Nguyen, P. N., Ho, Q. N. “Acute Fatty Liver Disease in Full-Term Pregnancy: A Case Report and Review of Literature.” J Med Case Reports, 2025.
4. Brown, A. N., Lange, M., Aliasi-Sinai, L., Zhang, X., Kogan, S., Martin, L., Kushner, T. “Adverse Pregnancy Outcomes and Effect of Treatment in Wilson Disease During Pregnancy: A Systematic Review and Meta-Analysis.” Liver International, 2024.
5. Brady, C. W. “Liver Disease in Pregnancy: What’s New.” Hepatology Communications, 2020; 4(2):145-156.
6. American Gastroenterological Association (AGA) Clinical Practice Update on Pregnancy-Related Gastrointestinal and Liver Disease: Expert Review. Gastroenterology, 2024.